Education
About Us
Working with TipRanks
Follow Us
John Peter Walker Insider Profile
4 Followers
John Peter Walker, Director at Geron, holds 116.51K shares in Zosano Pharma (Ticker: ZSANQ), holds 0.00 shares in Affymax (Ticker: AFFY), holds 39.12K shares in Geron (Ticker: GERN).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-65.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Peter Walker holds in companies
Most Profitable Insider Trade
Stock:
Zosano Pharma
(ZSANQ)
(ZSANQ)
Rating:Informative Buy
Date:Aug 22, 2016 - Aug 22, 2017
Return:-30.60%
The most profitable trade made by John Peter Walker
John Peter Walker's Trading History
Geron
Jan 30, 2009
Director
Informative Sell
402.55K
$67.68K
Zosano Pharma
Jun 29, 2020
―
Uninformative Buy
―
$2.33K
Affymax
Aug 29, 2013
Director
Informative Sell
31.76K
$0.00
Infinity Pharmaceuticals
―
Director
―
$0.00
Paratek Pharmaceuticals
―
―
―
$167.48K
List of latest transactions for each holding click on a transaction to see John Peter Walker's performance on stock
You May Also Like
John Peter Walker insider profile FAQ
What is the percentage of profitable transactions made by John Peter Walker?
The percentage of profitable transactions made by John Peter Walker is 0%.
What is the average return per transaction made by John Peter Walker?
The average return per transaction made by John Peter Walker is -65.10%.
What stocks does John Peter Walker hold?
John Peter Walker holds: GERN, ZSANQ, AFFY, INFIQ, PRTK stocks.
What was John Peter Walker’s latest transaction?
John Peter Walker latest transaction was an Uninformative Buy of ―.
What was John Peter Walker's most profitable transaction?
John Peter Walker’s most profitable transaction was an Informative Buy of ZSANQ stock on August 22, 2016. The return on the trade was -30.60%.
What is John Peter Walker's role in Geron?
John Peter Walker's role in Geron is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.